Maternal serum inhibin-A and free β-hCG concentrations in trisomy 21 pregnancies at 10 to 14 weeks of gestation

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 3, 1997, Pages 367-371

  Noble, P L ^a   Wallace, E M ^b   Snijders, R J M ^a   Groome, N P ^c   Nicolaides, K H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; INHIBIN A;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TRISOMY 21;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY WEIGHT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; INHIBINS; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 0031054423     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11470.x     Document Type: Article

References (23)

1. Schneyer AL, Mason AJ, Burton LE, Zeigne JR, Crowley WF. Immunoreactive inhibin β-subunit in human serum: Implications for radioimmunoassay. J Clin Endocrin Metabol 1990; 70: 1208–1212.
2. Robertson DM, Sullivan J, Cahir N. Inhibin forms in human plasma. J Endocrinol 1995; 144: 261–269.
3. Qu J, Thomas K. Inhibin and activin production in human placenta. EndocrRev 1995; 16: 485–507.
4. Groome NP, O'Brien M. Two-site immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. J Immunological Methods 1993; 165: 167–176.
5. Groome NP, Illingworth PJ, O'Brien M et al. Inhibin-B: A critical new hormone in the regulation of the female menstrual cycle. J Clin Endocrin Metabol 1996; 80: 2926–2932.
6. Illingworth PJ, Groome NP, Duncan WC et al. Measurement of circulating inhibin forms during the establishment of pregnancy. J Clin Endocrin Metabol 1996; 81: 1471–1475.
7. Tabei T, Ochiai K., Terashima Y, Takanashi N. Serum levels of inhibin in maternal and umbilical blood during pregnancy. Am J Obstet Gynecol 1991; 164: 896–900.
8. A dimer) during human pregnancy. Clin Endocrinol 1995; 42: 391–397.
9. Van Lith JMM, Pratt JJ, Beekuis JR, Mantingh A. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 1992; 12: 801–806.
10. Spencer K, Wood PJ, Anthony F W. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome. Ann Clin Biochem 1993; 30: 219–220.
11. Wallace EM, Harkness LM, Bums S, Listen WA. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome. Clin Endocrinol 1994; 41: 483–486.
12. Wallace EM, Swanston IA, McNeilly AS et al. Second trimester screening using maternal serum dimeric inhibin-A. Clin Endocrinol 1996; 44: 17–21.
13. Wallace EM, Grant VE, Swanston IA, Groome NP. Evaluation of maternal serum dimeric inhibin-A as a first trimester marker of Down's syndrome. PrenatDiagn 1995; 15: 359–362.
14. Cuckle HS, Holding S, Jones R et al. Maternal serum dimeric inhibin-A in second trimester Down's syndrome pregnancies. Prenat Diagn 1995; 15: 385–386.
15. Aitken DA, Wallace EM, Crossley JA et al. Dimeric Inhibin-A as a marker for Down's syndrome and trisomy 18 pregnancies at 7–18 weeks gestation. N Engl J Med 1996; 334: 1321–1326.
16. Groome NP, Illingworth PJ, O'Brien M et al. Detection of dimeric inhibin throughout the menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol 1994; 40: 717–723.
17. Noble PL, Abraha H, Snijders RJM et al. Screening for fetal trisomy 21 in the first trimester of pregnancy: Maternal serum free β-hCG and fetal nuchal translucency thickness. Ultrasound Obstet Gynaecol 1995; 6: 390–395.
18. Petralgia F, Sawchenko P, Lira ATW et al. Localisation, secretion and action of inhibin in human placenta. Science 1987; 237: 187–189.
19. Vaitukaitis JL, Ross GT, Braunstein GD. Gonadotrophins and their subunits: Basic and clinical studies. Recent Prog Harm Res 1976; 32: 289–331.
20. Petralgia F, Vaughan J, Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc Natl Acad Sci USA 1989; 86: 5114–5117.
21. Keelan J, Song Y, France JT. Comparative regulation of inhibin, activin and human chorionic gonadotropin production by placental trophoblast cells in culture. Placenta 1994; 15: 803–818.
22. Tovanabutra S, Illingworth PJ, Ledger WL et al. The relationship between peripheral immunoreactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy. Clin Endocrinol 1993; 38: 101–107.
23. Pandya PP, Snijders RJM, Johnson SP et al. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957–962.